Top Markets
Coin of the day
Omnimmune Holdings, Inc. Omnimmune Holdings, Inc.

Omnimmune Holdings, Inc.

OMMH
Rangering i aksjer #42527
Omnimmune Holdings, Inc., through its subsidiary, Omnimmune Corp., operates as... Omnimmune Holdings, Inc., through its subsidiary, Omnimmune Corp., operates as a development-stage biotechnology company integrating complementary cancer therapeutic, diagnostic, and prognostic technologies in the United States. The company owns rights for monoclonal antibody technologies. It also intends to develop personalized cancer treatment with the selection of prophylactic and therapeutic vaccines (active immunization), monoclonal antibodies (passive immunization), and genomic-based products, which target a hormone called human chorionic gonadotropin. In addition, the company plans to conduct a Phase I trial with its lead candidate anti-human chorionic gonadotropin beta subunit monoclonal antibodies based upon the results of the diagnostic trial. Omnimmune Holdings, Inc. is based in Houston, Texas.
Aksjekurs
$0.0001
Sist synkronisert: 2026-07-17
Markedsverdi
$981.00
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Omnimmune Holdings, Inc. (OMMH)

Kategori

Utbytteavkastning for Omnimmune Holdings, Inc. (OMMH)
Omnimmune Holdings, Inc. (aksjesymbol: OMMH) sin utbytteavkastning (TTM) per 2026 er: 0
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.00%
Utbytteavkastning for Omnimmune Holdings, Inc. (OMMH) fra 2026 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
År Utbytteavkastning Endre
Ikke nok data for de angitte datoene.
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter